AngioDynamics, Inc. (NASDAQ:ANGO – Free Report) – Equities researchers at Zacks Research cut their Q2 2025 EPS estimates for shares of AngioDynamics in a research note issued to investors on Monday, May 27th. Zacks Research analyst D. Dey now forecasts that the medical instruments supplier will earn ($0.15) per share for the quarter, down from […]
AngioDynamics, Inc (NASDAQ:ANGO) Sees Significant Decrease in Short Interest modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright restated their buy rating on shares of AngioDynamics (NASDAQ:ANGO – Free Report) in a research report report published on Wednesday morning, Benzinga reports. HC Wainwright currently has a $14.00 target price on the medical instruments supplier’s stock. HC Wainwright also issued estimates for AngioDynamics’ Q4 2024 earnings at ($0.21) EPS, Q2 2025 earnings […]
Q4 2024 EPS Estimates for AngioDynamics, Inc (NASDAQ:ANGO) Decreased by Analyst themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
AngioDynamics, Inc. (NASDAQ:ANGO – Get Free Report) CEO James C. Clemmer purchased 10,000 shares of the firm’s stock in a transaction that occurred on Monday, April 8th. The shares were acquired at an average cost of $6.70 per share, for a total transaction of $67,000.00. Following the purchase, the chief executive officer now owns 539,066 […]